Loading…
# Summary JBS Souderton, Inc., operating as MOPAC, received an FDA Warning Letter on April 23, 2019, regarding animal and veterinary products. While the specific violations cannot be detailed due to unavailable subject line information, the warning indicates regulatory concerns within the FDA's animal and veterinary product oversight scope. Without access to the full letter text, the exact nature and scope of the compliance issues remain unclear, though the formal warning suggests material violations requiring corrective action.